Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04945148
Title Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide (OPTIMUM)
Acronym OPTIMUM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hopital Foch
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA

Facility Status City State Zip Country Details
Foch Hospital RECRUITING Suresnes Hauts De Seine 92150 France Details
Hôpital Neurologique Pierre Wertheimer RECRUITING Bron Lyon 69500 France Details
Timone Hospital RECRUITING Marseille 13354 France Details
Saint Louis Hospital RECRUITING Paris 75010 France Details
Pitié Salpêtrière Hospital RECRUITING Paris 75013 France Details
Spidali Riuniti Di Livorno NOT_YET_RECRUITING Livorno Toscana Nord Ouest 57100 Italy Details
Istituto Nazionale Carlo Besta NOT_YET_RECRUITING Milano 20131 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field